Cervical Cancer Screening by Self-sampling in a Cohort of Younger Women in Ethiopia
-
- STATUS
- Recruiting
-
- End date
- Sep 24, 2024
-
- participants needed
- 1200
-
- sponsor
- Lund University
Summary
The overall purpose of the project is to evaluate an algorithm for an HPV self-sampling based cervical cancer screening algorithm in a mid-size town in Ethiopia that could be applicable for nationwide implementation in low and middle-income countries (LMIC).
Specific aims are the following:
- To evaluate the algorithm using Visual Inspection with Acetic acid (VIA) and VIA together with Lugol's Iodine (VILI) as triage and to use HPV self-sample to follow up those treated and those with persisting HPV.
- To evaluate the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae and their effect on the quality of VIA.
- To determine immune response profiles in high-risk HPV-positive women who cleared, persisted, or developed Cervical Intraepithelial Neoplasia 2/3 (CIN).
- To assess how specific cervicovaginal microbiota compositions are associated with HPV infection, cervical dysplasia, and cancer
Details
| Condition | Viral infection, Disorders of cervix NOS, carcinoma of cervix, sexually transmitted diseases, cervical cancer, uterine, Papillomaviridae, STI, carcinoma of the cervix uteri, Human Papilloma Virus (HPV), Metagenome, Venereal disease, Uterine Cancer, Gynecological Infections, sexually transmitted infections, sexually transmitted disease, Viral Infections, Sexually Transmitted Diseases (STDs), Cervical Cancer, Female Genital Diseases, carcinoma of the cervix, microbiota, Human Papilloma Virus, cancer of the cervix, Sexually Transmitted Infection, cervix cancer, Uterine Serous Carcinoma, cervical carcinoma |
|---|---|
| Treatment | VIA (Visual Inspection with Acetic acid) and VILI (Visual Inspection with Lugol's Iodine), VIA (Visual Inspection with Acetic acid) |
| Clinical Study Identifier | NCT05125380 |
| Sponsor | Lund University |
| Last Modified on | 24 November 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer